UroGen Pharma
URGN
URGN
71 hedge funds and large institutions have $469M invested in UroGen Pharma in 2018 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 23 increasing their positions, 19 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
3% less capital invested
Capital invested by funds: $482M → $469M (-$13.6M)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $359K
Holders
71
Holding in Top 10
3
Calls
–
Puts
$359K
Top Buyers
| 1 | +$6.88M | |
| 2 | +$5.86M | |
| 3 | +$4.67M | |
| 4 |
Man Group
London,
United Kingdom
|
+$4.03M |
| 5 |
MIH
Meitav Investment House
Bene-Beraq,
Israel
|
+$3.56M |
Top Sellers
| 1 | -$7.11M | |
| 2 | -$6.35M | |
| 3 | -$4.66M | |
| 4 |
BHB
Bank Hapoalim BM
Tel Aviv,
Israel
|
-$2.96M |
| 5 |
CBA
Coastal Bridge Advisors
Westport,
Connecticut
|
-$957K |